Enhancing Global Health Impact—Beyond the Basic Minimum, Metrics and Ethical Consumption

IF 1.4 3区哲学 Q2 ETHICS Public Health Ethics Pub Date : 2022-09-02 DOI:10.1093/phe/phac013

Nicole Hassoun

引用次数: 0

Abstract

How should we measure medicines’ global health impact to set targets, monitor performance and improve health around the world? Can such a metric provide a philosophically well-grounded basis for an ethical consumption campaign that will create incentives for pharmaceutical companies and other agents to expand (equitable) access to essential medicines? And if such metrics exist, how should we think about our individual obligations to support ethical consumption campaigns on this basis? This paper reflects on these questions in light of Tim Campbell’s, Yukiko Asada’s, and Andreas Albertsen’s worries about the answers I provide in Global Health Impact: Extending Access on Essential Medicines. I explain how reflecting on treatments consequences for individuals’ ability to live minimally well supports the creation of the Global Health Impact (GHI) index (https://global-health-impact.org/). I also consider how the index might be modified to better support efforts to promote everyone’s human rights. Finally, I argue that individuals should often promote positive change through GHI and other ethical consumption campaigns.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

增强全球健康影响——超越基本最低限度、衡量标准和道德消费

我们应该如何衡量药物对全球健康的影响，以制定目标、监测表现并改善世界各地的健康？这样一个指标能否为道德消费运动提供一个哲学上有根据的基础，从而激励制药公司和其他代理商扩大（公平）获得基本药物的机会？如果存在这样的指标，我们应该如何思考我们在这个基础上支持道德消费运动的个人义务？鉴于Tim Campbell、Yukiko Asada和Andreas Albertsen对我在《全球健康影响：扩大基本药物的获取》中提供的答案的担忧，本文对这些问题进行了反思。我解释了反思治疗对个人最低生活水平的影响如何支持全球健康影响（GHI）指数的创建(https://global-health-impact.org/)。我还考虑如何修改该指数，以更好地支持促进每个人人权的努力。最后，我认为个人应该经常通过GHI和其他道德消费活动来促进积极的变革。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Public Health Ethics PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-MEDICAL ETHICS

CiteScore

3.10

自引率

9.50%

发文量

审稿时长

>12 weeks

期刊介绍： Public Health Ethics invites submission of papers on any topic that is relevant for ethical reflection about public health practice and theory. Our aim is to publish readable papers of high scientific quality which will stimulate debate and discussion about ethical issues relating to all aspects of public health. Our main criteria for grading manuscripts include originality and potential impact, quality of philosophical analysis, and relevance to debates in public health ethics and practice. Manuscripts are accepted for publication on the understanding that they have been submitted solely to Public Health Ethics and that they have not been previously published either in whole or in part. Authors may not submit papers that are under consideration for publication elsewhere, and, if an author decides to offer a submitted paper to another journal, the paper must be withdrawn from Public Health Ethics before the new submission is made. The editorial office will make every effort to deal with submissions to the journal as quickly as possible. All papers will be acknowledged on receipt by email and will receive preliminary editorial review within 2 weeks. Papers of high interest will be sent out for external review. Authors will normally be notified of acceptance, rejection, or need for revision within 8 weeks of submission. Contributors will be provided with electronic access to their proof via email; corrections should be returned within 48 hours.